Impact of Semaglutide Treatment on Obesity Prevalence and CVD Events in US Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cardiovascular Drugs and Therapy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
US Population Eligibility and Estimated Impact of Semaglutide Treatment on Obesity Prevalence and Cardiovascular Disease Events
Cardiovasc Drugs Ther 2023 Aug 14;[EPub Ahead of Print], ND Wong, H Karthikeyan, W FanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.